HPLC Peptide Testing: How Research-Grade Purity Is Measured and Verified
By Dr. Leonard Haberman, Chief Science Officer, OPTMZ Peptides Published: March 2, 2026 | Last Updated: April 15, 2026 High-performance liquid chromatography (HPLC) is the primary analytical method used to measure peptide purity in research-grade compounds. When a Certificate of Analysis (COA) reports a purity percentage for a research peptide, that number almost always comes from HPLC data. Understanding what HPLC measures — and what it cannot — is essential context for any researcher evaluating compound quality. What Does HPLC Actually Measure in a Peptide Sample? HPLC does not test a peptide’s biological activity. It measures the compositional purity of a sample — specifically, what percentage of the detectable material in a vial corresponds to the target peptide versus other compounds. In reverse-phase HPLC (RP-HPLC), the method used for most peptide analysis, a liquid sample is pushed under high pressure through a column packed with hydrophobic stationary phase material. Compounds in the sample travel through the column at different rates depending on how strongly they interact with the stationary phase. The detector records a signal as each compound exits, producing a chromatogram: a graph of detector response over time. Each peak in a chromatogram represents a distinct compound. The target peptide produces the largest peak. Impurities, synthesis byproducts, degradation products, or residual reagents produce smaller secondary peaks. Purity is calculated as the area of the target peak divided by the total area of all detected peaks, expressed as a percentage. A sample reporting 99.2% purity means that 99.2% of the detectable material in that vial is the target peptide. The remaining 0.8% comprises everything else the detector can resolve. Why Reverse-Phase HPLC Is the Standard for Peptide Research Three properties of RP-HPLC make it the preferred method for research peptide analysis: Sensitivity to hydrophobic differences. Peptides vary in hydrophobicity depending on their amino acid sequence. RP-HPLC separates compounds based on these differences with sufficient resolution to distinguish a target peptide from closely related impurities, including truncated sequences, deletion sequences, or oxidation products. Studies validating RP-HPLC for peptide purity assessment have confirmed its suitability for detecting impurities at sub-1% levels (Mant & Hodges, 1991, Journal of Chromatography A PubMed). Reproducibility. Properly calibrated RP-HPLC systems generate consistent results across repeated injections of the same sample, making it a reliable basis for batch-to-batch comparison. Compatibility with standard COA reporting. HPLC purity values expressed as area-under-curve percentages are the accepted format for research-grade compound certificates of analysis. This standardization allows researchers to compare purity data across vendors using a consistent metric. For research applications where compound consistency directly affects experimental outcomes, RP-HPLC purity data is the minimum acceptable quality documentation. Research examining peptide stability has noted that purity degradation as small as 2–3% can introduce measurable variability in in vitro assay results (Bhatt et al., 2011, International Journal of Peptides PubMed). How to Read an HPLC Chromatogram on a Peptide COA When reviewing a COA from OPTMZ Peptides, the “Lab Analysis” tab provides the HPLC result for that specific batch. Here is how to interpret the key components: The main peak retention time. This is the time point at which the target peptide elutes from the column. Retention time is characteristic of the compound’s structure. A shift in retention time between batches can indicate a structural difference. The peak area percentage. This is the purity figure. On OPTMZ COAs, the minimum accepted purity is 98.0% — batches testing below this threshold are rejected before entering inventory. Most batches test between 98.5% and 99.9%. Secondary peaks. Minor peaks are expected and do not indicate a failed batch unless they exceed acceptable limits. The identity of secondary peaks requires mass spectrometry — HPLC alone can detect them but cannot confirm what they are. The baseline. A flat, stable baseline with clearly resolved peaks indicates a clean, well-executed analysis. An unstable or noisy baseline may indicate column degradation or sample preparation issues; it does not necessarily invalidate the result but warrants scrutiny. For a direct example: In Batch #BPC-2026-03-15, HPLC analysis of BPC-157 returned 99.4% purity as measured by Krause Analytical. The chromatogram showed a single dominant peak at the expected retention time with no secondary peaks exceeding 0.2% area. The full COA for this batch is available in the OPTMZ COA Vault. What HPLC Cannot Confirm Alone HPLC purity data answers one question: how much of the sample is the target compound. It does not answer: Identity. A sample could theoretically achieve a high HPLC purity figure while being the wrong compound. Identity confirmation requires mass spectrometry (MS), which verifies the molecular weight and fragmentation pattern of the compound. HPLC and MS are used together on every OPTMZ batch for this reason. Endotoxin levels. Bacterial endotoxins are not detectable by HPLC. Endotoxin testing (LAL method) is a separate required test for research-grade peptides. Residual solvents or heavy metals. These contaminants require dedicated analytical methods — ICP-MS for metals, headspace GC for residual solvents. A COA that reports only HPLC purity is incomplete for research purposes. OPTMZ’s standard testing panel covers seven methods: HPLC (purity), mass spectrometry (identity), endotoxin (LAL), heavy metals (ICP-MS), microbial, pH stability, and visual inspection — all conducted by Krause Analytical, a DEA-registered, ISO/IEC 17025-certified laboratory in Austin, TX. Batch-to-Batch Consistency: Why Single-Batch HPLC Data Is Insufficient A single high-purity result does not establish that a supplier’s process is consistent. Research settings require reproducible inputs: a compound that tests at 99.1% in one batch but 96.0% in the next introduces an uncontrolled variable into any experimental protocol. Evaluating a vendor’s HPLC history across multiple batches is the only reliable way to assess process consistency. The OPTMZ COA Vault maintains a searchable archive of published COA results by batch number — accessible directly from the vial label. Researchers can verify the purity of the specific batch in hand, compare it against prior batches, and assess whether the supplier’s process is stable over time. No competitor publishes a historical COA archive with batch-level searchability. HPLC Purity as a
